LOGIN  |  REGISTER
Chimerix
Compass Therapeutics

Molina Healthcare Announces the Closing of its Acquisition of My Choice Wisconsin

September 05, 2023 | Last Trade: US$332.38 3.12 -0.93

LONG BEACH, Calif. / Sep 05, 2023 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of My Choice Wisconsin (“MCW”) closed on September 1, 2023. As of June 30, 2023, MCW served over 44,000 members.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company (currently ranked 126), provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 5.2 million members as of June 30, 2023. For more information about Molina Healthcare, please visit molinahealthcare.com.

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page